Publications by authors named "Tushar Sinha"

Claim this Profile
C
Comment on: 'AI deepfake: GPT-4o can produce near-authentic fundus images'.
Debdulal Chakraborty, Tushar Kanti Sinha

Eye (Lond)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biosimilar Versus Innovator Ranibizumab in Myopic CNVM: Comparative Real-World Outcomes- The BRIM Study.
Debdulal Chakraborty, Tushar Kanti Sinha, Sourav Sinha, Rupak Kanti Biswas, Aniruddha Maiti

Clin Ophthalmol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-based assessment of temporomandibular disorders in complete denture versus partial denture users: a systematic review.
Jayant Prakash, Tushar Sinha, Hiroj Bagde, Nirupama Rajegowda, Sneha Bhat

Minerva Dent Oral Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of acrylic splints on bite force among dentulous patients.
Madhu Ranjan, Surender Kumar, Daya Shankar, Ananya Singh, Tushar Sinha

Bioinformation· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CompaRative Safety Analysis of Innovator and BioSimilar Ranibizumab in Chorioretinal Vascular Diseases - The CRsIBS Study.
Debdulal Chakraborty, Tushar Kanti Sinha, Sourav Sinha, Rupak Kanti Biswas, Aniruddha Maiti

Clin Ophthalmol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled Multicenter Safety Analysis of Lupin's Intravitreal Biosimilar Ranibizumab (Ranieyes) in Chorioretinal Vascular Diseases.
Debdulal Chakraborty, Tushar Kanti Sinha, Sourav Sinha, Aniruddha Maiti, Angshuman Mukherjee

Ophthalmol Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovator ranibizumab ComparEd to Biosimilar ranibizumab in combination with Expansile gas in submaculaR HemorrhaGe: the ICEBERG study.
Debdulal Chakraborty, Tushar Kanti Sinha, Soumen Mondal, Subhendu Boral, Arnab Das

BMC Ophthalmol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Evaluation of Faricimab in Real-World Diabetic Macular Edema in India- A Multicenter Observational Study.
Debdulal Chakraborty, Sudipta Das, Aniruddha Maiti, Tushar Kanti Sinha, Arnab Das

Clin Ophthalmol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brolucizumab versus aflibercept for recalcitrant diabetic macular edema in Indian real-world scenario - The BRADIR study.
Debdulal Chakraborty, Ashish Sharma, Soumen Mondal, Jay Sheth, Tushar Kanti Sinha

Am J Ophthalmol Case Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transitioning from Aflibercept to Biosimilar Ranibizumab in Diabetic Macular Edema (DME): (The TRANSFORM-DME Trial) a Multicenter Observational Study.
Debdulal Chakraborty, Tushar Kanti Sinha, Aniruddha Maiti, Subhendu Kumar Boral, Arnab Das

Clin Ophthalmol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aflibercept vs. dexamethasone implant for recalcitrant diabetic macular edema in pseudophakic eyes - 1-year outcomes from a quazi-randomized study in India.
Debdulal Chakraborty, Soumen Mondal, Sabyasachi Sengupta, Aniruddha Maiti, Subhendu Boral, Tushar K Sinha

Indian J Ophthalmol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transitioning from Aflibercept to Biosimilar Ranibizumab in Neovascular AMD (The TRANSFORM Trial): A Multicenter Observational Study.
Debdulal Chakraborty, Subhendu Boral, Tushar Kanti Sinha, Arnab Das, Angshuman Mukherjee

Clin Ophthalmol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of large-scale use of vancomycin injection in infusion bottle during vitreoretinal procedures.
Subhendu Kumar Boral, Deepak Agarwal, Arnab Das, Debdulal Chakraborty, Santanu Mandal, Tushar Kanti Sinha

Oman J Ophthalmol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does hormone replacement therapy impact implant osseointegration in females- A systematic review and meta-analysis.
Tushar Sinha, Jayant Prakash, Mahesh Suganna Golgeri, Daginakatti Shambhulingappa Aruna, Bukanakere Sangappa Sunila

Saudi Dent J· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the Capability to Accurately Capture the Vertical Relationship by the Various Bite Registration Materials.
Priya Rani, Madhu Ranjan, Tushar Sinha, Ananya Singh, Mritunjay Keshri

J Pharm Bioallied Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maxillary Cast Partial Denture and Mandibular Implant-Supported Metal-Ceramic Prosthesis With a Split Framework to Compensate for Mandibular Flexure: A Case Report.
Ananya, Priya Rani, Tushar Sinha, Jayant Prakash

Cureus· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of post vitrectomy endophthalmitis in India - A multicentric study by VRSI study Group.
Payal Naresh Shah, Divyansh K Mishra, Mahesh P Shanmugam, Manisha Agarwal, Pradeep Susvar, Tushar Sinha

Eye (Lond)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparison of the Wetting Ability of Three Artificial Saliva Substitutes on Heat-Cured Denture Base Resin - An Study.
Madhu Ranjan, Mritunjay Kumar Keshari, Tushar Sinha, Mehtaab Singh Bhatia, Priya Rani

J Pharm Bioallied Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biosimilar versus InnovAtor MoLecule of RAnibizumab in Neovascular Age-Related MaCular DEgeneration (The BALANCE Trial): Real-World Evidence.
Debdulal Chakraborty, Soumen Mondal, Subhendu Boral, Arnab Das, Tushar Kanti Sinha

Clin Ophthalmol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Clinical Study Comparing the Maxillary Anterior Tooth Shade and Fabricated Crown Shade of the Western Uttar Pradesh Population to Commercial Shade Guides.
Tushar Sinha, Madhu Ranjan, Ujjal Chatterjee, Dharmendra K Sinha, Aditya Chaudhary

Cureus· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brolucizumab in Neovascular Age-Related Macular Degeneration - Indian Real-World Experience: The BRAILLE Study - Fifty-Two-Week Outcomes.
Debdulal Chakraborty, Aniruddha Maiti, Jay U Sheth, Soumen Mondal, Subhendu Boral, Tushar Kanti Sinha

Clin Ophthalmol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rehabilitation of Phthisis Bulbi using Thick Scleral Shell Prosthesis.
Anuraj Vijayan, Anju Aggarwal, Punit R S Khurana, Tushar Sinha

Int J Appl Basic Med Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Innovator vs. Biosimilar Ranibizumab in Treating Diabetic Macular Edema: A Multicenter Retrospective Study.
Debdulal Chakraborty, Sabyasachi Sengupta, Soumen Mondal, Subhendu Boral, Arnab Das, Tushar Kanti Sinha

Ophthalmol Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Off-label intravitreal brolucizumab for recalcitrant diabetic macular edema: A real-world case series.
Debdulal Chakraborty, Jay U Sheth, Subhendu Boral, Tushar K Sinha

Am J Ophthalmol Case Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brolucizumab in Neovascular Age-Related Macular Degeneration - Indian Real-World Experience: The BRAILLE Study.
Debdulal Chakraborty, Aniruddha Maiti, Jay U Sheth, Subhendu Boral, Soumen Mondal, Tushar Sinha

Clin Ophthalmol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis